Shanghai Lily&Beauty Cosmetics Co.,Ltd.
SSE:605136.SS
7.72 (CNY) • At close May 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,728.186 | 2,762.392 | 3,241.531 | 4,154.854 | 4,599.796 | 3,874.468 | 3,614.813 | 3,420.274 | 2,015.798 | 1,217.248 | 715.636 | 381.881 |
| Cost of Revenue
| 1,107.859 | 1,807.542 | 2,364.493 | 2,640.201 | 2,948.446 | 2,494.694 | 2,290.623 | 2,216.282 | 1,303.903 | 781.316 | 442.347 | 241.627 |
| Gross Profit
| 620.327 | 954.85 | 877.038 | 1,514.653 | 1,651.35 | 1,379.774 | 1,324.189 | 1,203.992 | 711.895 | 435.932 | 273.289 | 140.254 |
| Gross Profit Ratio
| 0.359 | 0.346 | 0.271 | 0.365 | 0.359 | 0.356 | 0.366 | 0.352 | 0.353 | 0.358 | 0.382 | 0.367 |
| Reseach & Development Expenses
| 23.435 | 12.271 | 12.002 | 11.025 | 11.905 | 11.024 | 22.39 | 19.75 | 13.55 | 0 | 0 | 0 |
| General & Administrative Expenses
| 55.488 | 61.854 | 48.474 | 48.343 | 27.66 | 27.255 | 22.551 | 14.351 | 53.461 | 40.155 | 27.444 | 20.781 |
| Selling & Marketing Expenses
| 351.795 | 683.493 | 727.526 | 836.105 | 1,018.196 | 960.759 | 942.919 | 819.777 | 545.299 | 345.083 | 232.711 | 109.692 |
| SG&A
| 407.284 | 737.523 | 776 | 884.448 | 1,045.856 | 988.014 | 965.47 | 834.128 | 598.76 | 385.239 | 260.155 | 130.473 |
| Other Expenses
| 204.506 | 160.75 | 44.601 | 24.628 | 48.331 | 1.017 | 1.944 | 0.762 | 5.37 | 2.664 | -0.218 | 0.918 |
| Operating Expenses
| 635.225 | 910.543 | 832.602 | 920.101 | 1,106.091 | 1,000.054 | 1,036.439 | 909.561 | 618.836 | 388.794 | 261.855 | 131.639 |
| Operating Income
| -14.898 | 44.307 | 58.715 | 543.705 | 443.897 | 366.569 | 345.425 | 291.258 | 93.704 | 40.369 | 8.277 | 7.354 |
| Operating Income Ratio
| -0.009 | 0.016 | 0.018 | 0.131 | 0.097 | 0.095 | 0.096 | 0.085 | 0.046 | 0.033 | 0.012 | 0.019 |
| Total Other Income Expenses Net
| -2.123 | -0.784 | -0.955 | -3.066 | -1.185 | -0.002 | 1.944 | 0.762 | 5.37 | 2.603 | -0.218 | 0.918 |
| Income Before Tax
| -17.021 | 43.523 | -171.707 | 540.639 | 442.712 | 366.567 | 347.369 | 292.02 | 99.074 | 42.972 | 8.058 | 8.271 |
| Income Before Tax Ratio
| -0.01 | 0.016 | -0.053 | 0.13 | 0.096 | 0.095 | 0.096 | 0.085 | 0.049 | 0.035 | 0.011 | 0.022 |
| Income Tax Expense
| 9.187 | 16.285 | -28.319 | 130.824 | 104.911 | 82.085 | 95.681 | 66.344 | 18.369 | 10.26 | 2.376 | 3.175 |
| Net Income
| -24.4 | 29.528 | -143.388 | 410.737 | 339.481 | 285.994 | 252.297 | 227.217 | 81.1 | 32.713 | 5.682 | 5.096 |
| Net Income Ratio
| -0.014 | 0.011 | -0.044 | 0.099 | 0.074 | 0.074 | 0.07 | 0.066 | 0.04 | 0.027 | 0.008 | 0.013 |
| EPS
| -0.061 | 0.07 | -0.36 | 1.03 | 0.85 | 0.72 | 0.7 | 0.63 | 0.22 | 0.089 | 0.015 | 0.014 |
| EPS Diluted
| -0.061 | 0.07 | -0.36 | 1.03 | 0.85 | 0.72 | 0.7 | 0.63 | 0.22 | 0.089 | 0.015 | 0.014 |
| EBITDA
| 2.715 | 64.438 | -145.791 | 555.157 | 447.44 | 375.653 | 353.008 | 298.777 | 105.042 | 49.834 | 13.612 | 10.332 |
| EBITDA Ratio
| 0.002 | 0.023 | -0.045 | 0.134 | 0.097 | 0.097 | 0.098 | 0.087 | 0.052 | 0.041 | 0.019 | 0.027 |